Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Holtzman

Showing results (561-570 of 742) with videos related to

Pageof 75
Sort By:
Annals of Neurology|February 7, 2021
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy ModelAlexandra Litvinchuk, Tien-Phat V Huynh, Yang Shi, et al.
Journal of Neuroinflammation|June 20, 2020
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent mannerMan Ying Wong, Michael Lewis, James J Doherty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2012
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 miceAndrew W Kraft, Xiaoyan Hu, Hyejin Yoon, et al.
Acta Neuropathologica Communications|August 8, 2022
Corpora amylacea are associated with tau burden and cognitive status in Alzheimer's diseaseConnor M Wander, Tamy Harumy Moraes Tsujimoto, John F Ervin, et al.
Brain : a Journal of Neurology|July 22, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomesJustin M Long, Dean W Coble, Chengjie Xiong, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient miceN Ho, J A Liauw, F Blaeser, et al.
Brain : a Journal of Neurology|June 12, 2016
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imagingBrian A Gordon, Karl Friedrichsen, Matthew Brier, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Brain : a Journal of Neurology|May 29, 2012
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-βRobert M Koffie, Tadafumi Hashimoto, Hwan-Ching Tai, et al.
Pageof 75

Showing results (561-570 of 742) with videos related to

Sort By:
Pageof 75
Annals of Neurology|February 7, 2021
Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy ModelAlexandra Litvinchuk, Tien-Phat V Huynh, Yang Shi, et al.
Journal of Neuroinflammation|June 20, 2020
25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent mannerMan Ying Wong, Michael Lewis, James J Doherty, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 6, 2012
Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 miceAndrew W Kraft, Xiaoyan Hu, Hyejin Yoon, et al.
Acta Neuropathologica Communications|August 8, 2022
Corpora amylacea are associated with tau burden and cognitive status in Alzheimer's diseaseConnor M Wander, Tamy Harumy Moraes Tsujimoto, John F Ervin, et al.
Brain : a Journal of Neurology|July 22, 2022
Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomesJustin M Long, Dean W Coble, Chengjie Xiong, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 31, 2000
Impaired synaptic plasticity and cAMP response element-binding protein activation in Ca2+/calmodulin-dependent protein kinase type IV/Gr-deficient miceN Ho, J A Liauw, F Blaeser, et al.
Brain : a Journal of Neurology|June 12, 2016
The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imagingBrian A Gordon, Karl Friedrichsen, Matthew Brier, et al.
Neurology|March 1, 2006
Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer diseaseE R Siemers, J F Quinn, J Kaye, et al.
Neurology|September 10, 2021
Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PETSuzanne E Schindler, Yan Li, Virginia D Buckles, et al.
Brain : a Journal of Neurology|May 29, 2012
Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-βRobert M Koffie, Tadafumi Hashimoto, Hwan-Ching Tai, et al.
Pageof 75